BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12486224)

  • 1. ARF mutation accelerates pituitary tumor development in Rb+/- mice.
    Tsai KY; MacPherson D; Rubinson DA; Nikitin AY; Bronson R; Mercer KL; Crowley D; Jacks T
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16865-70. PubMed ID: 12486224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance.
    Hu N; Gutsmann A; Herbert DC; Bradley A; Lee WH; Lee EY
    Oncogene; 1994 Apr; 9(4):1021-7. PubMed ID: 8134105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin.
    Harvey M; Vogel H; Lee EY; Bradley A; Donehower LA
    Cancer Res; 1995 Mar; 55(5):1146-51. PubMed ID: 7867001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
    Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
    J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development.
    Carneiro C; Jiao MS; Hu M; Shaffer D; Park M; Pandolfi PP; Cordon-Cardo C; Koff A
    Oncogene; 2003 Jan; 22(3):361-9. PubMed ID: 12545157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype.
    King D; Yang G; Thompson MA; Hiebert SW
    Oncogene; 2002 Jul; 21(32):4978-82. PubMed ID: 12118376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis.
    Guo Z; Yikang S; Yoshida H; Mak TW; Zacksenhaus E
    Cancer Res; 2001 Dec; 61(23):8395-400. PubMed ID: 11731416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incomplete inhibition of the Rb tumor suppressor pathway in the context of inactivated p53 is sufficient for pancreatic islet tumorigenesis.
    Casanovas O; Hager JH; Chun MG; Hanahan D
    Oncogene; 2005 Oct; 24(44):6597-604. PubMed ID: 16007165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
    Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
    Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.
    Semczuk A; Marzec B; Roessner A; Jakowicki JA; Wojcierowski J; Schneider-Stock R
    Virchows Arch; 2002 Dec; 441(6):577-83. PubMed ID: 12461615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the Arf/p53 tumor surveillance network by E2F.
    Iaquinta PJ; Aslanian A; Lees JA
    Cold Spring Harb Symp Quant Biol; 2005; 70():309-16. PubMed ID: 16869767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to tumors induced in mice by ethylnitrosourea is independent of retinoblastoma gene dosage.
    Riley DJ; Lai CC; Chang CY; Jones D; Lee EY; Lee WH
    Cancer Res; 1994 Dec; 54(23):6097-101. PubMed ID: 7954454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse.
    Vooijs M; van der Valk M; te Riele H; Berns A
    Oncogene; 1998 Jul; 17(1):1-12. PubMed ID: 9671308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens.
    Morgenbesser SD; Williams BO; Jacks T; DePinho RA
    Nature; 1994 Sep; 371(6492):72-4. PubMed ID: 8072529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Earlier onset of melanotroph carcinogenesis in mice with inherited mutant paternal allele of the retinoblastoma gene.
    Nikitin AY; Riley DJ; Lee WH
    Cancer Res; 1997 Oct; 57(19):4274-8. PubMed ID: 9331088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor suppressor genes and their role in abnormal production of leukocytes (leukemogenesis)].
    Furukawa Y
    Rinsho Ketsueki; 1993 May; 34(5):572-7. PubMed ID: 8315827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.